Sponsored Links
| Merz Pharmaceuticals Announces New Centers For Medicare And Medicaid Billing Q-Code For Xeomin(R) (IncobotulinumtoxinA) |
 |
 |
 |
| Medical News - Medical Practice Management | |||
|
Merz Pharmaceuticals, LLC announced today that the Centers for Medicare and Medicaid Services (CMS) has granted a unique Healthcare Common Procedure Coding System (HCPCS) billing code, Q2040, for Xeomin®(incobotulinumtoxinA)... Read more: Medical Practice Management News From Medical News Today
|